These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25691815)

  • 41. Implementation of a pharmacogenomics service in a community pharmacy.
    Ferreri SP; Greco AJ; Michaels NM; O'Connor SK; Chater RW; Viera AJ; Faruki H; McLeod HL; Roederer MW
    J Am Pharm Assoc (2003); 2014; 54(2):172-80. PubMed ID: 24632932
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Examination of why some community pharmacists do not provide 72-hour emergency prescription drugs to Medicaid patients when prior authorization is not available.
    Shepherd MD
    J Manag Care Pharm; 2013 Sep; 19(7):523-33. PubMed ID: 23964613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Implementation of a pharmacist-led pharmacogenomics service for the Program of All-Inclusive Care for the Elderly (PHARM-GENOME-PACE).
    Bain KT; Schwartz EJ; Knowlton OV; Knowlton CH; Turgeon J
    J Am Pharm Assoc (2003); 2018; 58(3):281-289.e1. PubMed ID: 29602745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Perceptions of pharmacists' role in the health care team through student-pharmacist led point-of-care screenings and its future application in health care.
    Bastianelli KMS; Nelson L; Palombi L
    Curr Pharm Teach Learn; 2017; 9(2):195-200. PubMed ID: 29233403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing.
    Roederer MW; Van Riper M; Valgus J; Knafl G; McLeod H
    Per Med; 2012 Jan; 9(1):19-27. PubMed ID: 29783293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population.
    Lee YM; Manzoor BS; Cavallari LH; Nutescu EA
    Pharmacotherapy; 2018 Feb; 38(2):205-216. PubMed ID: 29286540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bringing clinical pharmacogenomics information to pharmacists: A qualitative study of information needs and resource requirements.
    Romagnoli KM; Boyce RD; Empey PE; Adams S; Hochheiser H
    Int J Med Inform; 2016 Feb; 86():54-61. PubMed ID: 26725696
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
    Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
    Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations.
    Morley KI; Hall WD
    J Mol Med (Berl); 2004 Jan; 82(1):21-30. PubMed ID: 14598045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A survey on awareness of the "finger-tip unit" and medication guidance for the use of topical steroids among community pharmacists.
    Oishi N; Iwata H; Kobayashi N; Fujimoto K; Yamaura K
    Drug Discov Ther; 2019 Jul; 13(3):128-132. PubMed ID: 31204366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of pharmacogenomics in drug discovery and development.
    Surendiran A; Pradhan SC; Adithan C
    Indian J Pharmacol; 2008 Aug; 40(4):137-43. PubMed ID: 20040945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Community pharmacists' perceptions about pharmaceutical service of over-the-counter traditional Chinese medicine: a survey study in Harbin of China.
    Song M; Ung CO; Lee VW; Hu Y; Zhao J; Li P; Hu H
    BMC Complement Altern Med; 2017 Jan; 17(1):9. PubMed ID: 28056935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ASHP Statement on the Pharmacist's Role in Clinical Pharmacogenomics.
    Haidar CE; Petry N; Oxencis C; Douglas JS; Hoffman JM
    Am J Health Syst Pharm; 2022 Apr; 79(8):704-707. PubMed ID: 34487145
    [No Abstract]   [Full Text] [Related]  

  • 54. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
    Hafner S; Haubensak S; Paul T; Zolk O
    Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
    [No Abstract]   [Full Text] [Related]  

  • 55. Independent prescribing by pharmacists: a study of the awareness, views and attitudes of Scottish community pharmacists.
    George J; Pfleger D; McCaig D; Bond C; Stewart D
    Pharm World Sci; 2006 Apr; 28(2):45-53. PubMed ID: 16752193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacy benefit managers, pharmacies, and pharmacogenomic testing: prescription for progress?
    Topol EJ
    Sci Transl Med; 2010 Aug; 2(44):44cm22. PubMed ID: 20702854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacogenomics resources support pharmacists' need to know.
    Thompson CA
    Am J Health Syst Pharm; 2013 Sep; 70(18):1560, 1564. PubMed ID: 23988594
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacogenetic Information in Clinical Guidelines: The European Perspective.
    Swen JJ; Nijenhuis M; van Rhenen M; de Boer-Veger NJ; Buunk AM; Houwink EJF; Mulder H; Rongen GA; van Schaik RHN; van der Weide J; Wilffert B; Deneer VHM; Guchelaar HJ;
    Clin Pharmacol Ther; 2018 May; 103(5):795-801. PubMed ID: 29460273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Feasibility and Acceptability of a Pharmacogenomic Decision Support System in Palliative Care.
    Bull JH; Bice T; Satterwhite WJ; Massie L; Burpee E; Knotkova H; Portenoy RK
    J Palliat Med; 2022 Feb; 25(2):219-226. PubMed ID: 34714127
    [No Abstract]   [Full Text] [Related]  

  • 60. [Cooperation according to French Law "hospital, patients, health and territories": Pharmacists' involvement in Aquitaine region].
    d'Elbée M; Baumevieille M; Dumartin C
    Rev Epidemiol Sante Publique; 2017 Jun; 65(3):231-239. PubMed ID: 28262371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.